Literature DB >> 21257741

Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.

Jin-fen Li1, Jonathan T Lipscomb, Xierong Wei, Neil A Martinson, Lynn Morris, Walid Heneine, Jeffrey A Johnson.   

Abstract

To substantiate reports of greater emergence of the K65R nucleoside reverse transcriptase inhibitor (NRTI) mutation in human immunodeficiency virus type 1 (HIV-1) subtype C, we examined natural low-level K65R expression in subtype C relative to subtypes B and AE. We used allele-specific polymerase chain reaction to screen HIV-1 amplified by reverse-transcription high-fidelity polymerase chain reaction from subtype C-infected South African women and infants and CRF01(subtype AE) from Thailand; all subjects were NRTI naive. We found low-level K65R of unknown clinical significance in NRTI-naive subtype C-infected women and infants at frequencies above the natural occurrence in subtypes B and AE. The frequent appearance of subtype C frameshift deletions at codon 65 supports a propensity for transcription error in this region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257741      PMCID: PMC3071134          DOI: 10.1093/infdis/jiq126

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.

Authors:  Dan Turner; Eduardo Shahar; Eugene Katchman; Eynat Kedem; Natasha Matus; Michal Katzir; Gamal Hassoun; Shimon Pollack; Rivka Kessner; Mark A Wainberg; Boaz Avidor
Journal:  J Med Virol       Date:  2009-09       Impact factor: 2.327

2.  Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Lynn Morris; Neil Martinson; Glenda Gray; James McIntyre; Walid Heneine
Journal:  J Infect Dis       Date:  2005-06-01       Impact factor: 5.226

3.  Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

Authors:  Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha Taha
Journal:  J Infect Dis       Date:  2005-06-01       Impact factor: 5.226

4.  Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.

Authors:  Dimitrios Coutsinos; Cédric F Invernizzi; Hongtao Xu; Daniela Moisi; Maureen Oliveira; Bluma G Brenner; Mark A Wainberg
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

5.  Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).

Authors:  Jorge L Martinez-Cajas; Nitika P Pai; Marina B Klein; Mark A Wainberg
Journal:  J Int AIDS Soc       Date:  2009-06-30       Impact factor: 5.396

6.  Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.

Authors:  Neil A Martinson; Lynn Morris; Jeffrey Johnson; Glenda E Gray; Visva Pillay; Johanna Ledwaba; Puleng Dhlamini; Sarah Cohen; Adrian Puren; Jan Steyn; Walid Heneine; James A McIntyre
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

7.  The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

Authors:  Mina C Hosseinipour; Joep J G van Oosterhout; Ralf Weigel; Sam Phiri; Debbie Kamwendo; Neil Parkin; Susan A Fiscus; Julie A E Nelson; Joseph J Eron; Johnstone Kumwenda
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

8.  HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.

Authors:  Visva Pillay; Candice Pillay; Rami Kantor; Francois Venter; Leon Levin; Lynn Morris
Journal:  AIDS Res Hum Retroviruses       Date:  2008-11       Impact factor: 2.205

9.  Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Xierong Wei; Jonathan Lipscomb; Diane Bennett; Ashley Brant; Mian-Er Cong; Thomas Spira; Robert W Shafer; Walid Heneine
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

10.  Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Xierong Wei; Jonathan Lipscomb; David Irlbeck; Charles Craig; Amanda Smith; Diane E Bennett; Michael Monsour; Paul Sandstrom; E Randall Lanier; Walid Heneine
Journal:  PLoS Med       Date:  2008-07-29       Impact factor: 11.069

View more
  14 in total

1.  Inefficient vaginal transmission of tenofovir-resistant HIV-1.

Authors:  Morgan Chateau; Michael D Swanson; J Victor Garcia
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

2.  Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis.

Authors:  Dara A Lehman; Jared M Baeten; Connor O McCoy; Julie F Weis; Dylan Peterson; Gerald Mbara; Deborah Donnell; Katherine K Thomas; Craig W Hendrix; Mark A Marzinke; Lisa Frenkel; Patrick Ndase; Nelly R Mugo; Connie Celum; Julie Overbaugh; Frederick A Matsen
Journal:  J Infect Dis       Date:  2015-01-13       Impact factor: 5.226

3.  Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.

Authors:  Xierong Wei; Gillian Hunt; Salim S Abdool Karim; Vivek Naranbhai; Sengeziwe Sibeko; Quarraisha Abdool Karim; Jin-Fen Li; Angela D M Kashuba; Lise Werner; Jo-Ann S Passmore; Lynn Morris; Walid Heneine; Jeffrey A Johnson
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

Review 4.  Are subtype differences important in HIV drug resistance?

Authors:  R J Lessells; D K Katzenstein; T de Oliveira
Journal:  Curr Opin Virol       Date:  2012-09-21       Impact factor: 7.090

5.  Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.

Authors:  Christopher J Hoffmann; Johanna Ledwaba; Jin-Fen Li; Victoria Johnston; Gillian Hunt; Katherine L Fielding; Richard E Chaisson; Gavin J Churchyard; Alison D Grant; Jeffrey A Johnson; Salome Charalambous; Lynn Morris
Journal:  Antivir Ther       Date:  2013-06-10

6.  Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.

Authors:  Herbert A Mbunkah; Silvia Bertagnolio; Raph L Hamers; Gillian Hunt; Seth Inzaule; Tobias F Rinke De Wit; Roger Paredes; Neil T Parkin; Michael R Jordan; Karin J Metzner
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

7.  Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean immigrant.

Authors:  Vineeta Bansal; Karin J Metzner; Barbara Niederost; Christine Leemann; Jurg Boni; Huldrych F Gunthard; Jan S Fehr
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

8.  A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1.

Authors:  Dimitrios Coutsinos; Cédric F Invernizzi; Daniela Moisi; Maureen Oliveira; Jorge L Martinez-Cajas; Bluma G Brenner; Mark A Wainberg
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data.

Authors:  Patricia Recordon-Pinson; Jennifer Papuchon; Sandrine Reigadas; Alaka Deshpande; Hervé Fleury
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

10.  Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).

Authors:  Urvi M Parikh; Photini Kiepiela; Shayhana Ganesh; Kailazarid Gomez; Stephanie Horn; Krista Eskay; Cliff Kelly; Barbara Mensch; Pamina Gorbach; Lydia Soto-Torres; Gita Ramjee; John W Mellors
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.